Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guérin

Objective: To report prognostic factors and follow-up data for an unselected group of patients with carcinoma in situ (CIS) of the urinary bladder treated with bacille Calmette-Guérin (BCG). Material and Methods: The clinical records of patients with CIS treated with BCG were reviewed. All 173 patie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scand J Urol Nephrol 2004, Vol.38 (4), p.285-290
Hauptverfasser:	Andius, Patrik, Damm, Ole, Holmäng, Sten
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravesical Adult Aged Aged, 80 and over bacille Calmette-Guérin BCG Vaccine - therapeutic use Biological and medical sciences Biopsy, Needle bladder cancer carcinoma in situ Carcinoma in Situ - drug therapy Carcinoma in Situ - mortality Carcinoma in Situ - pathology Confidence Intervals Cystoscopy Disease-Free Survival Dose-Response Relationship, Drug Drug Administration Schedule Female Humans Immunohistochemistry Male Medical sciences MEDICIN MEDICINE Middle Aged Neoplasm Staging Nephrology. Urinary tract diseases Prognosis Proportional Hazards Models Retrospective Studies Risk Assessment Survival Analysis Sweden Treatment Outcome Tumors of the urinary system Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - mortality Urinary Bladder Neoplasms - pathology Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Urologi och njurmedicin Urology and Nephrology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!